205 related articles for article (PubMed ID: 22700039)
1. Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.
Sofuoglu M; Herman AI; Li Y; Waters AJ
Psychopharmacology (Berl); 2012 Dec; 224(3):413-20. PubMed ID: 22700039
[TBL] [Abstract][Full Text] [Related]
2. Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.
Sofuoglu M; Herman AI; Mooney M; Waters AJ
Psychopharmacology (Berl); 2009 Nov; 207(1):153-62. PubMed ID: 19693492
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
4. Effects of galantamine on smoking behavior and cognitive performance in treatment-seeking smokers prior to a quit attempt.
MacLean RR; Waters AJ; Brede E; Sofuoglu M
Hum Psychopharmacol; 2018 Jul; 33(4):e2665. PubMed ID: 29926988
[TBL] [Abstract][Full Text] [Related]
5. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
6. Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.
Sofuoglu M; Poling J; Mouratidis M; Kosten T
Psychopharmacology (Berl); 2006 Mar; 184(3-4):645-51. PubMed ID: 16432681
[TBL] [Abstract][Full Text] [Related]
7. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.
Myers CS; Taylor RC; Moolchan ET; Heishman SJ
Neuropsychopharmacology; 2008 Feb; 33(3):588-98. PubMed ID: 17443125
[TBL] [Abstract][Full Text] [Related]
8. Self-administration of intravenous nicotine in male and female cigarette smokers.
Sofuoglu M; Yoo S; Hill KP; Mooney M
Neuropsychopharmacology; 2008 Mar; 33(4):715-20. PubMed ID: 17534380
[TBL] [Abstract][Full Text] [Related]
9. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers.
Sofuoglu M; Mitchell E; Mooney M
Hum Psychopharmacol; 2009 Oct; 24(7):559-64. PubMed ID: 19743227
[TBL] [Abstract][Full Text] [Related]
10. Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers.
Herman AI; Waters AJ; McKee SA; Sofuoglu M
Psychopharmacology (Berl); 2012 Apr; 220(3):611-7. PubMed ID: 21947318
[TBL] [Abstract][Full Text] [Related]
11. Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers.
Sofuoglu M; Mouratidis M; Yoo S; Culligan K; Kosten T
Psychopharmacology (Berl); 2005 Sep; 181(3):504-10. PubMed ID: 15983800
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
Jones JD; Babalonis S; Marcus R; Vince B; Kelsh D; Lofwall MR; Fraser H; Paterson B; Martinez S; Martinez DM; Nunes EV; Walsh SL; Comer SD
Addict Biol; 2020 Jul; 25(4):e12799. PubMed ID: 31240842
[TBL] [Abstract][Full Text] [Related]
13. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
14. Modafinil and nicotine interactions in abstinent smokers.
Sofuoglu M; Waters AJ; Mooney M
Hum Psychopharmacol; 2008 Jan; 23(1):21-30. PubMed ID: 17868195
[TBL] [Abstract][Full Text] [Related]
15. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE
J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055
[TBL] [Abstract][Full Text] [Related]
16. Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial.
Diehl A; Nakovics H; Croissant B; Smolka MN; Batra A; Mann K
Int J Clin Pharmacol Ther; 2006 Dec; 44(12):614-22. PubMed ID: 17190371
[TBL] [Abstract][Full Text] [Related]
17. Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers.
Reid MS; Palamar J; Raghavan S; Flammino F
Psychopharmacology (Berl); 2007 May; 192(1):147-58. PubMed ID: 17345064
[TBL] [Abstract][Full Text] [Related]
18. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: Safety and subjective effects.
Walele T; Sharma G; Savioz R; Martin C; Williams J
Regul Toxicol Pharmacol; 2016 Feb; 74():193-9. PubMed ID: 26702788
[TBL] [Abstract][Full Text] [Related]
19. Nicotine dependence (trait) and acute nicotinic stimulation (state) modulate attention but not inhibitory control: converging fMRI evidence from Go-Nogo and Flanker tasks.
Lesage E; Sutherland MT; Ross TJ; Salmeron BJ; Stein EA
Neuropsychopharmacology; 2020 Apr; 45(5):857-865. PubMed ID: 31995811
[TBL] [Abstract][Full Text] [Related]
20. Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.
Piper ME; Cook JW; Schlam TR; Jorenby DE; Baker TB
Addiction; 2011 Feb; 106(2):418-27. PubMed ID: 20973856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
